북미의 IV 하이드레이션 요법 시장 규모, 점유율과 동향 분석 보고서 : 서비스별, 컴포넌트별, 프로바이더 유형별, 최종 용도별, 국가별, 부문 예측(2026-2033년)

North America IV Hydration Therapy Market Summary

The North America IV hydration therapy market size was estimated at USD 1.35 billion in 2025 and is projected to reach USD 2.56 billion by 2033, growing at a CAGR of 8.6% from 2026 to 2033. The market is primarily driven by heightened consumer emphasis on proactive health management, the shift toward preventive wellness, and increasing demand for convenient, on-demand healthcare services.

Post-pandemic health consciousness has significantly accelerated the adoption of intravenous (IV) hydration as a lifestyle and recovery solution. In parallel, the growing incidence of fatigue, migraines, and nutrient deficiencies has expanded the therapeutic scope of IV therapy beyond traditional clinical use.

The North America IV hydration therapy industry is rising, owing to the increasing prevalence of chronic diseases such as cancer and diabetes. According to the CDC estimates of February 2024, around 129 million people in the US have at least 1 major chronic disease, creating a strong demand for effective healthcare solutions. IV hydration therapy is a crucial player, offering a direct and quick way to address the consequences and management of chronic diseases. It becomes a valuable tool in improving the well-being of individuals facing these conditions. As chronic diseases become more common, the market is stepping up to provide specialized care and support for those who need it.

Increasing awareness of the benefits of IV hydration therapies among North America's population is boosting the market growth. According to the National Institute of Health and Care Excellence, numerous adult patients require Intravenous (IV) fluid therapy to address to fluid and electrolyte balance. IV therapy is a therapeutic intervention that delivers fluids directly into the bloodstream to restore hydration and revitalize the body. Remarkably, IV hydration offers a faster and more complete absorption of vitamins, electrolytes, and antioxidants than oral intake, as it avoids the digestive system.

IV hydration therapy is utilized across multiple clinical areas to ensure rapid and effective fluid and electrolyte management. In emergency and critical care, it provides immediate resuscitation for trauma, shock, sepsis, and acute dehydration. For gastrointestinal disorders, it helps manage fluid loss from severe vomiting, diarrhea, or inflammatory bowel conditions. Post-surgical care relies on IV therapy to maintain fluid balance, deliver medications, and support recovery when oral intake is limited. In oncology, it prevents dehydration and fatigue during chemotherapy and radiation, while in chronic disease management, it supports patients with diabetes, renal, or cardiovascular conditions who have restricted oral intake.

The increasing demand for IV hydration therapy is also driven by the shift toward convenient, personalized wellness options that go beyond traditional clinical care. For instance, in August 2025, AquaPulse IV introduced mobile IV therapy services in Fredericksburg, Virginia. The service provides customized hydration and vitamin infusions directly to clients' homes, workplaces, or events, administered by licensed medical professionals. Such development shows how IV therapy is becoming part of a lifestyle and preventive health approach, offering people quick recovery, energy boosts, and immune support in environments that fit their daily routines. These on-demand models highlight the rising focus on accessibility and patient-centered care in wellness services.

North America IV Hydration Therapy Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends across sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the North America IV hydration therapymarket report based on service, component, provider type, end use, and regions.

• Service Outlook (Revenue, USD Million, 2021 - 2033)
• Immune Boosters
• Energy Boosters
• Hydration
• Beauty/ Aesthetics
• Detoxification
• Longevity/ Antiaging
• Performance/ Athletics
• Migraine & Pain Relief
• Stress/Sleep/Mood Support
• Flu/Stomach
• Others
• Component Outlook (Revenue, USD Million, 2021 - 2033)
• Medicated
• Non-medicated
• Provider Type Outlook (Revenue, USD Million, 2021 - 2033)
• Mobile Providers
• Physical Providers
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals & Clinics
• Wellness Centers and Spas
• Home Healthcare
• Others
• Country Outlook (Revenue, USD Million, 2021 - 2033)
• U.S.
• Canada
• Mexico

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Service
  • 1.2.2. Component
  • 1.2.3. Provider Type
  • 1.2.4. End use
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Growing demand for quick rehydration and recovery solutions
    • 3.2.1.2. Increasing adoption of wellness and preventive healthcare trends
    • 3.2.1.3. Rising popularity of IV nutrient therapy for beauty, skin rejuvenation, and anti-aging benefits
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Risk of side effects, including infections, vein inflammation, or allergic reactions
    • 3.2.2.2. High cost of treatments compared to oral supplements and conventional care
    • 3.2.2.3. Limited insurance coverage, making therapies less accessible to many patients
  • 3.2.3. Industry Opportunity Analysis
  • 3.2.4. Industry Challenge Analysis
  • 3.2.5. Pricing Analysis
  • 3.2.6. Emerging Trends
• 3.3. Business Environment Analysis
  • 3.3.1. Porter's Five Forces Analysis
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTLE Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
    • 3.3.2.5. Legal Landscape

Chapter 4. North America IV Hydration Therapy Market: Service Estimates & Trend Analysis

• 4.1. Service Segment Dashboard
• 4.2. Service Market Share Movement Analysis, 2025 & 2033
• 4.3. Market Size & Forecasts and Trend Analysis, by Service, 2021 to 2033 (USD Million)
• 4.4. Immune Boosters
  • 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Energy Boosters
  • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Hydration
  • 4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.7. Beauty/ Aesthetics
  • 4.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.8. Detoxification
  • 4.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.9. Longevity/ Antiaging
  • 4.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.10. Performance/ Athletics
  • 4.10.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.11. Migraine & Pain Relief
  • 4.11.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.12. Stress/Sleep/Mood Support
  • 4.12.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.13. Flu/Stomach
  • 4.13.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.14. Others
  • 4.14.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. North America IV Hydration Therapy Market: Component Estimates & Trend Analysis

• 5.1. Component Segment Dashboard
• 5.2. Component Market Share Movement Analysis, 2025 & 2033
• 5.3. Market Size & Forecasts and Trend Analysis, by Component, 2021 to 2033 (USD Million)
• 5.4. Medicated
  • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Non-Medicated
  • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. North America IV Hydration Therapy Market: Provider Type Estimates & Trend Analysis

• 6.1. Provider Type Dashboard
• 6.2. Provider Type Market Share Movement Analysis, 2025& 2033
• 6.3. Market Size & Forecasts and Trend Analysis, by Provider Type, 2021 to 2033 (USD Million)
• 6.4. Mobile Providers
  • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Physical Providers
  • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. North America IV Hydration Therapy Market: End Use Estimates & Trend Analysis

• 7.1. End use Segment Dashboard
• 7.2. End use Market Share Movement Analysis, 2025 & 2033
• 7.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 7.4. Healthcare Providers
  • 7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.5. Hospitals & Clinics
  • 7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. Wellness Centers & Spas
  • 7.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.7. Home Healthcare
  • 7.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.8. Others
  • 7.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. North America IV Hydration Therapy Market: Country Estimates & Trend Analysis

• 8.1. Country Market Dashboard
• 8.2. Country Market: Key Takeaways
• 8.3. U.S.
  • 8.3.1. Key country dynamic
  • 8.3.2. Regulatory framework
  • 8.3.3. Competitive insights
  • 8.3.4. U.S. IV Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
• 8.4. Canada
  • 8.4.1. Key country dynamic
  • 8.4.2. Regulatory framework
  • 8.4.3. Competitive insights
  • 8.4.4. Canada IV Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
• 8.5. Mexico
  • 8.5.1. Key country dynamic
  • 8.5.2. Regulatory framework
  • 8.5.3. Competitive insights
  • 8.5.4. Mexico IV Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Participant Overview
• 9.2. Company Market Position Analysis
• 9.3. Company Categorization
• 9.4. Strategy Mapping
• 9.5. Company Profiles/Listing
  • 9.5.1. Baxter
    • 9.5.1.1. Overview
    • 9.5.1.2. Financial performance
    • 9.5.1.3. Product benchmarking
    • 9.5.1.4. Strategic initiatives
  • 9.5.2. B. Braun SE
    • 9.5.2.1. Overview
    • 9.5.2.2. Financial performance
    • 9.5.2.3. Product benchmarking
    • 9.5.2.4. Strategic initiatives
  • 9.5.3. Otsuka Pharmaceutical Co., Ltd.
    • 9.5.3.1. Overview
    • 9.5.3.2. Financial performance
    • 9.5.3.3. Product benchmarking
    • 9.5.3.4. Strategic initiatives
  • 9.5.4. Grifols, S.A.
    • 9.5.4.1. Overview
    • 9.5.4.2. Financial performance
    • 9.5.4.3. Product benchmarking
    • 9.5.4.4. Strategic initiatives
  • 9.5.5. Vifor Pharma Management Ltd.
    • 9.5.5.1. Overview
    • 9.5.5.2. Financial performance
    • 9.5.5.3. Product benchmarking
    • 9.5.5.4. Strategic initiatives
  • 9.5.6. JW Life Science Corporation
    • 9.5.6.1. Overview
    • 9.5.6.2. Financial performance
    • 9.5.6.3. Product benchmarking
    • 9.5.6.4. Strategic initiatives
  • 9.5.7. Amanta Healthcare
    • 9.5.7.1. Overview
    • 9.5.7.2. Financial performance
    • 9.5.7.3. Product benchmarking
    • 9.5.7.4. Strategic initiatives
  • 9.5.8. NexGen Health
    • 9.5.8.1. Overview
    • 9.5.8.2. Financial performance
    • 9.5.8.3. Product benchmarking
    • 9.5.8.4. Strategic initiatives
  • 9.5.9. Core IV Therapy, LLC
    • 9.5.9.1. Overview
    • 9.5.9.2. Financial performance
    • 9.5.9.3. Product benchmarking
    • 9.5.9.4. Strategic initiatives
  • 9.5.10. Drip Hydration
    • 9.5.10.1. Overview
    • 9.5.10.2. Financial performance
    • 9.5.10.3. Product benchmarking
    • 9.5.10.4. Strategic initiatives
  • 9.5.11. REVIV
    • 9.5.11.1. Overview
    • 9.5.11.2. Financial performance
    • 9.5.11.3. Product benchmarking
    • 9.5.11.4. Strategic initiatives
  • 9.5.12. DriPros IV Hydration Wellness
    • 9.5.12.1. Overview
    • 9.5.12.2. Financial performance
    • 9.5.12.3. Product benchmarking
    • 9.5.12.4. Strategic initiatives
  • 9.5.13. wHydrate
    • 9.5.13.1. Overview
    • 9.5.13.2. Financial performance
    • 9.5.13.3. Product benchmarking
    • 9.5.13.4. Strategic initiatives
  • 9.5.14. Renew Ketamine & Wellness Center
    • 9.5.14.1. Overview
    • 9.5.14.2. Financial performance
    • 9.5.14.3. Product benchmarking
    • 9.5.14.4. Strategic initiatives
  • 9.5.15. R2 Medical Clinic
    • 9.5.15.1. Overview
    • 9.5.15.2. Financial performance
    • 9.5.15.3. Product benchmarking
    • 9.5.15.4. Strategic initiatives
  • 9.5.16. AliveDrip
    • 9.5.16.1. Overview
    • 9.5.16.2. Financial performance
    • 9.5.16.3. Product benchmarking
    • 9.5.16.4. Strategic initiatives
  • 9.5.17. Hydrate IV
    • 9.5.17.1. Overview
    • 9.5.17.2. Financial performance
    • 9.5.17.3. Product benchmarking
    • 9.5.17.4. Strategic initiatives
  • 9.5.18. Hydration Room
    • 9.5.18.1. Overview
    • 9.5.18.2. Financial performance
    • 9.5.18.3. Product benchmarking
    • 9.5.18.4. Strategic initiatives